Clinical trial
Short Course Nitrofurantoin for Acute Cystitis
NCT00391651 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00391651 |
|---|---|
| Title | Short Course Nitrofurantoin for Acute Cystitis |
| Official title | Short Course Nitrofurantoin For Acute Cystitis |
| Lead sponsor | University of Washington, Other |
| Collaborators | Procter and Gamble Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urinary Tract Infection |
| Intervention type | Drug |
| Interventions | Nitrofurantoin 100mg twice daily x 5 days, TMP/SMX DS twice daily x 3 days |
| Enrollment | 338 |
| Start date | Jan 1, 2002 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Oct 24, 2006 |
| Last update posted | Jun 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: